NASDAQ: CNSP
Cns Pharmaceuticals Inc Stock Ownership - Who owns Cns Pharmaceuticals?

Insider buying vs selling

Have Cns Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Faith L. CharlesDirector2026-05-187,100$4.79
$34.00kBuy

1 of 1

CNSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNSP insiders and whales buy or sell their stock.

CNSP Shareholders

What type of owners hold Cns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cortice Biosciences Inc39.23%573,368$2.80MInsider
John M. Climaco14.76%215,676$1.05MInsider
Waldemar Priebe10.73%156,807$766.79kInsider
Christopher Downs7.08%103,438$505.81kInsider
Stonepine Capital Management LLC4.17%61,000$298.29kInstitution
Ikarian Capital LLC3.14%45,830$224.11kInstitution
Jerzy Gumulka2.94%43,006$210.30kInsider
Carl Anthony Evans2.29%33,458$163.61kInsider
Geode Capital Management LLC1.59%23,189$113.39kInstitution
Boothbay Fund Management LLC0.93%13,524$66.13kInstitution

1 of 2

CNSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNSP9.96%78.28%Net BuyingNet Buying
SILO82.63%17.37%Net Buying
APM1.92%25.63%
ADXN0.00%15.05%
ACXP4.26%59.85%

Cns Pharmaceuticals Stock Ownership FAQ

Who owns Cns Pharmaceuticals?

Cns Pharmaceuticals (NASDAQ: CNSP) is owned by 9.96% institutional shareholders, 78.28% Cns Pharmaceuticals insiders, and 11.76% retail investors. Cortice Biosciences Inc is the largest individual Cns Pharmaceuticals shareholder, owning 573,368.00 shares representing 39.23% of the company. Cortice Biosciences Inc's Cns Pharmaceuticals shares are currently valued at $2.72M.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.